Chemical tools to investigate sphingolipid metabolism and functions

被引:51
作者
Delgado, Antonio [1 ,2 ]
Casas, Josefina [1 ]
Llebaria, Amadeu [1 ]
Abad, Jose Luis [1 ]
Fabrias, Gemma [1 ]
机构
[1] CSIC, IIQAB, Dept Quim Organ Biol, Res Unit Bioact Mol,RUBAM, Jordi Girona 18-26, ES-08034 Barcelona, Spain
[2] Univ Barcelona, Fac Farm, CSIC, Unitat Quim Farmaceut, Barcelona 08028, Spain
关键词
ACID BETA-GLUCOSIDASE; DIHYDROCERAMIDE DESATURASE INHIBITOR; NEUTRAL SPHINGOMYELINASE INHIBITOR; FLUORESCENT CERAMIDE ANALOG; PROTEIN-KINASE-C; SPHINGOSINE; 1-PHOSPHATE; BIOLOGICAL EVALUATION; GAUCHER-DISEASE; GALBONOLIDE-B; CELL-DEATH;
D O I
10.1002/cmdc.200600195
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Sphingolipids comprise an important group of biomolecules, some of which have been shown to play important roles in the regulation of many cell functions. From a structural standpoint, they all share a long 2-amino-1,3-diol chain, which can be either saturated (sphinganine), hydroxylated at C4 (phytosphingosine), or unsaturated at C4 (sphingosine) as in most mammalian cells. N-acylation of sphingosine leads to ceramide, a key intermediate in sphingolipd metabolism that can be enzymatically modified at the C1-OH position to other biologically important sphingolipids, such as sphingomyelin or glycosphingolipids. In addition, both ceramide and sphingosine can be phosphorylated at C1-OH to give ceramide-l-phosphate and sphingosine-l-phosphate, respectively. To better understand the biological and biophysical roles of sphingolipids, many efforts have been made to design synthetic analogues as chemical tools able to unravel their structure-activity relationships, and to alter their cellular levels. This last approach has been thoroughly studied by the development of specific inhibitors of some key enzymes that play an important role in biosynthesis or metabolism of these intriguing lipids. With the above premises in mind, the aim of this review is to collect, in a systematic way, the recent efforts described in the literature leading to the development of new chemical entities specifically designed to achieve the above goals.
引用
收藏
页码:580 / 606
页数:27
相关论文
共 260 条
[1]   GALBONOLIDE-A AND GALBONOLIDE-B - 2 NEW NON-GLYCOSIDIC ANTIFUNGAL MACROLIDES FROM STREPTOMYCES-GALBUS [J].
ACHENBACH, H ;
MUHLENFELD, A ;
ZAHNER, H .
TETRAHEDRON LETTERS, 1985, 26 (50) :6167-6170
[2]   Biochemistry of glycosphingolipid storage disorders: implications for therapeutic intervention [J].
Aerts, JM ;
Hollak, C ;
Boot, R ;
Groener, A .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2003, 358 (1433) :905-914
[3]   Miglustat (NB-DNJ) works as a chaperone for mutated acid β-glucosidase in cells transfected with several Gaucher disease mutations [J].
Alfonso, P ;
Pampín, S ;
Estrada, J ;
Rodríguez-Rey, JC ;
Giraldo, P ;
Sancho, J ;
Pocoví, M .
BLOOD CELLS MOLECULES AND DISEASES, 2005, 35 (02) :268-276
[4]   Stimulation of CD95-induced apoptosis in T-cells by a subtype specific neutral sphingomyelinase inhibitor [J].
Amtmann, E ;
Zöller, M .
BIOCHEMICAL PHARMACOLOGY, 2005, 69 (08) :1141-1148
[5]  
Amtmann E, 1996, DRUG EXP CLIN RES, V22, P287
[6]  
ANTES P, 1992, EUR J CELL BIOL, V59, P27
[7]  
Arenz C, 2001, CHEMBIOCHEM, V2, P141, DOI 10.1002/1439-7633(20010202)2:2<141::AID-CBIC141>3.0.CO
[8]  
2-P
[9]   Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase [J].
Arenz, C ;
Gartner, M ;
Wascholowski, V ;
Giannis, A .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (11) :2901-2904
[10]  
Arenz C, 2000, ANGEW CHEM INT EDIT, V39, P1440, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1440::AID-ANIE1440>3.0.CO